Researchers studying the differential expression of microRNA say they may have discovered a way to treat autism by reversing the effects of the disease.
Taken together with recently published research regarding “DNA tagging” by methylation, they say their new study in Genome medicine illustrates two different “epigenetic” mechanisms controlling gene activity in autism that lie beyond genetic mutations. While methylation inhibits gene expression at the level of DNA, microRNA inhibits at the level of RNA.
MicroRNA are snippets of RNA, each of which can inhibit the expression of hundreds to more than a thousand genes. The effects of microRNA are also reversible by treatment with complementary “anti-sense” RNA.
The George Washington University team identified changes in the profile of microRNAs between identical twins and sibling pairs, discordant for diagnosis of autism. They discovered that, despite using cells derived originally from blood, brain-specific and brain-related microRNAs were found to be differentially expressed in the autistic samples, and that these microRNAs could potentially regulate genes that control many processes known to be disrupted in autism.
For example, differentially expressed microRNAs were found to regulate genes highly involved in neurological functions and disorders in addition to genes involved in gastrointestinal diseases, circadian rhythm signaling, and steroid hormone metabolism.
The study further shows that by treating the cells with “anti-sense” RNA antagonists to specific microRNA or by employing mimics of a particular microRNA, one can reverse the pattern of expression of a given target gene regulated by that microRNA.
“It is becoming increasingly clear that many factors, genetic as well as epigenetic, contribute to the manifestation of autism spectrum disorders,” said Valerie Hu, from the University's School of Medicine. “Epigenetic factors are particularly interesting as they provide potential mechanisms for introducing environmental effects into this complex disorder.”
Citation: Sarachana et al., 'Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines', Genome Medicine, April 2010, 2(23); doi:10.1186/gm144
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Sam Ting On AMS Results: Dark Matter Might Be One Seminar Away
- Vitriolic Abuse Of Anita Sarkeesian: Why The Games Industry Needs Her
- Why Natural Gas, Including Fracking, Is Better For The Environment Than Wind And Solar
- Graphene Sensor Tracks Down Cancer Biomarkers
- BICEP2's vision wasn't that strong, Planck says their window was too dusty.
- Nature Communications Switching To Exclusive Open Access
- 15 Biomarkers: Blood Test May Determine Risk For Psychosis
- "1.) Fundamentally one can never prove any theory. That's what makes a theory different from..."
- "I thank you for your comment, which I think is very important. Especially the question aboutPerhaps..."
- "I know what you mean, that is why I wrote sim Evo in . ;-)..."
- "You derive this how? ;-)..."
- "Whoa, careful there. If you say something the blogger doesn't like, you might find it hidden due..."
- Does the belief in guardian angels make people more cautious?
- Aberrant PI3K/AKT/mTOR pathway found in vestibular schwanommas may be therapeutic target
- A multi-function protein is key to stopping genomic parasites from 'jumping'
- Presence or absence of early language delay alters anatomy of the brain in autism
- News from Annals of Internal Medicine tip sheet -- Sept. 23, 2014